Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population

Creative Commons License

Aksu A. E. K., SARAÇOĞLU Z. N., METİNTAŞ S., Sabuncu I., Cetin Y.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.1, ss.66-72, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/anatoljcardiol.2016.6679
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.66-72
  • Anahtar Kelimeler: Framingham risk score, metabolic syndrome, psoriasis, CORONARY-HEART-DISEASE, OBESE-PATIENTS, PREVALENCE, DIAGNOSIS, MODERATE, THERAPY, ASSOCIATION, PREDICTION, STRESS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Psoriasis is associated with an increased frequency of cardiovascular risk factors. Metabolic syndrome ( MS) and the Framingham risk score (FRS) are two different algorithms for evaluating cardiovascular risk. They include different features: waist circumference measurement is included in the MS criteria, whereas smoking, age, and gender are questioned in FRS. This study aimed to evaluate the frequency of MS and FRS in psoriasis patients compared with a control group and investigate the differences between MS and FRS.